Evaluating Celecoxib Activity in Mycobacterium Tuberculosis: A Whole Blood Bactericidal Activity Study in Healthy Volunteers

NCT02602509 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis

Interventions

DRUG: Celecoxib
DRUG: Rifampicin
DRUG: Pyrazinamide

Sponsor

National University Hospital, Singapore